INSTYTUT CHEMII BIOORGANICZNEJ PAN

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169
 
 
 
C07K PEPTIDES 1135

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9562080 Lyme disease vaccine, genetic construct, recombinant protein, method for designing genetic construct, method for producing vaccine, method for producing recombinant proteins, use of recombinant proteins in the production of lyme disease vaccineOct 21, 13Feb 07, 17[A61K, C12N, C07K]
9206209 Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical compositionOct 13, 11Dec 08, 15[A61K, C07H, A01N, C07F]
9051559 Peptide with the enzymatic activity of a Dicer-like protein, a method for preparing short RNA molecules, and use thereofJun 25, 12Jun 09, 15[C12P, C12N]
9040490 Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor, a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal DNA methylationMar 17, 11May 26, 15[A61K, C07H, A01N, C07D]
8946400 Sequence of dsRNA: ATN-RNA specific for tenascin-CJul 30, 07Feb 03, 15[C07H, C12N]
8404660 Method of obtaining of 4-N-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-N-furfurylcytosine and/or its derivatives in the manufacture of anti-aging compositionNov 25, 08Mar 26, 13[A61K, A01N]
7923578 Method of manufacturing 3-(4-hydroxyphenyl)propanoic acid amide, its application in the manufacture of anti-aging compositions and anti-aging compositionOct 18, 06Apr 12, 11[C07C]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0044,675 MODIFIED GENE OF HUMAN ACTIVATION-INDUCED CYTIDINE DEAMINASE (AID), A METHOD OF MODIFICATION OF HUMAN AID GENE, A COMPOSITION SHOWING AID ACTIVITY, A METHOD OF PREPARATION OF SUCH COMPOSITION IN A BACTERIAL SYSTEM AND USE OF THE COMPOSITION IN THE ANALYSES OF DNA/RNA AMINATION/DEAMINATION AND/OR METHYLATION/DEMETHYLATIONAbandonedJan 14, 14Feb 12, 15[C12Q, C12N]
2013/0053,258 COMBINATORIAL LIBRARY, A METHOD FOR PREPARATION OF THAT COMBINATORIAL LIBRARY, A METHOD FOR SEQUENCE IDENTIFICATION, A METHOD FOR SEQUENCING THE ELEMENTS OF COMBINATORIAL LIBRARIES OF OLIGONUCLEOTIDES AND/OR OLIGONUCLEOTIDE ANALOGUES, THE USE OF A LINKER TO GENERATE COMBINATORIAL LIBRARIES AND A SEQUENCE IDENTIFICATION SETAbandonedMar 21, 11Feb 28, 13[C40B]
2011/0207,197 METHOD TO INHIBIT RIBONUCLEASE DICER, RIBONUCLEASE DICER INHIBITOR, AND USE OF RNA APTAMERS AS RIBONUCLEASE DICER INHIBITORSAbandonedFeb 09, 09Aug 25, 11[C07H, C12N]
2011/0060,574 COMPUTER-BASED MODELING AND DESIGNING OF PHOSPHOFRUCTOKINASE 1 (PFK) MODULATORSAbandonedNov 25, 08Mar 10, 11[C07F, G06F]
2010/0286,429 CRYSTALLOGRAPHIC MODEL OF THE BINDING SITE AND A MODULATOR REGULATING THE CATALYTIC ACTIVITY OF PHOSPHOFRUCTOKINASE (PFK), A METHOD OF DESIGNING, SELECTING AND PRODUCING THE PFK MODULATOR, A COMPUTER-BASED METHOD FOR THE ANALYSIS OF THE INTERACTIONS BETWEEN THE MODULATOR AND PFKAbandonedNov 25, 08Nov 11, 10[C07F, C07C, G06F, G06G]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.